Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Form 8 (OPD) IndigoVision Group PLC

20th Mar 2020 07:00

RNS Number : 8821G
IndigoVision Group PLC
20 March 2020
 

FORM 8 (OPD)

 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

INDIGOVISION GROUP PLC

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

INDIGOVISION GROUP PLC

(d) Is the discloser the offeror or the offeree?

OFFEREE

(e) Date position held:

The latest practicable date prior to the disclosure

18 MARCH 2020

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

 

Class of relevant security:

 

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

Nil

-

Nil

-

(2) Cash-settled derivatives:

 

Nil

-

Nil

-

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

Nil

-

Nil

-

 

TOTAL:

Nil

-

Nil

-

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

(b) Rights to subscribe for new securities

 

Class of relevant security in relation to which subscription right exists:

None

Details, including nature of the rights concerned and relevant percentages:

None

 

 

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:

 

Holdings of Ordinary Shares by directors of IndigoVision Group plc (the "Company")

 

Name

Number of Ordinary Shares held

Percentage of total issued share capital carrying voting rights (excluding Ordinary Shares held in treasury)(1)

Max Thowless-Reeves (Chairman)(2)

157,383

2.14

Pedro Vasco Simoes (CEO)

30,262

0.41

Chris Lea (CFO)

39,344

0.54

George Elliott (Non-Executive Director)

18,000

0.25

Vikki MacLeod (Non-Executive Director)

10,000

0.14

 

(1) Based on a total voting share capital of 7,337,940

(2) Max Thowless-Reeves is founding partner of Sorbus Partners LLP, which manages VT Sorbus Vector Fund, which is holding 460,000 Ordinary Shares in the capital of the Company, equivalent to 6.27% of the total voting share capital

 

Holdings of options over Ordinary Shares by directors of the Company

 

2008 LTIP

 

Name

Number of options over Ordinary Shares held

Exercise price of options

Vesting period of options

Pedro Vasco Simoes (CEO)

22,848

£0.00

October 2020 - October 2030

Chris Lea (CFO)

18,393

£0.00

March 2020 - March 2030

 

2018 LTIP

 

Name

Number of IVG Units held

Pedro Vasco Simoes (CEO)

375

Chris Lea (CFO)

375

 

Each 'IVG Unit' entitles the holder to share in a pool of Ordinary Shares equivalent to up to 20% of the Company's issued share capital at the date of exercise, the distribution of which will be dependent on (a) the level of the Company's earnings per share delivered in the 2021 financial year and (b) the proportion of total of IVG Units held by the director (out of a total pool of up to 1,000 IVG Units).

 

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

[None]

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

[None]

 

 

(c) Attachments

 

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

 

 

Date of disclosure:

19 March 2020

Contact name:

Chris Lea

Telephone number:

0131 475 7200

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
FEESFAFWUESSEFD

Related Shares:

IND.L
FTSE 100 Latest
Value8,809.74
Change53.53